• 主题
高级搜索  >
历史搜索 清空历史
首页> 外国专利> Method of inhibiting protein tyrosine phosphatase 1B and/or T-cell protein tyrosine phosphatase 4 and/or other PTPases with an Asp residue at position 48

Method of inhibiting protein tyrosine phosphatase 1B and/or T-cell protein tyrosine phosphatase 4 and/or other PTPases with an Asp residue at position 48

机译：抑制蛋白酪氨酸磷酸酶1B和/或T细胞蛋白酪氨酸磷酸酶4和/或其他PTP酶在48位具有Asp残基的方法

页面导航
  • 摘要
  • 著录项
  • 相似文献

摘要

The present invention provides a method of inhibiting a member of a family of Protein Tyrosine Phosphatases (PTPases, PTPs) such as PTP1B, TC-PTP, CD45, SHP-1, SHP-2, PTPα, PTPε, PTPμ, PTPδ, PTPσ, PTPζ, PTPβ, PTPD1, PTPD2, PTPH1, PTP-MEG1, PTP-LAR, and HePTP by exposing said Ptpase member by administration to a host or otherwise to at least one compound with certain structural, physical and spatial characteristics that allow for the interaction of said compound with specific residues of the active site of PTP1B and/or TC-PTP. These compounds are indicated in the management or treatment of a broad range of diseases such as autoimmune diseases, acute and chronic inflammation, osteoporosis, various forms of cancer and malignant diseases, and type I diabetes and type II diabetes, as well as in the isolation of PTPases and in elucidation or further elucidation of their biological function.
机译：本发明提供了抑制蛋白酪氨酸磷酸酶（PTPases，PTP）家族的成员的方法，所述蛋白例如PTP1B，TC-PTP，CD45，SHP-1，SHP-2，PTPα，PTPε，PTPμ，PTPδ，PTPσ， PTPζ，PTPβ，PTPD1，PTPD2，PTPH1，PTP-MEG1，PTP-LAR和HePTP，方法是将所述Ptpase成员暴露于宿主或以其他方式暴露于具有一定结构，物理和空间特征的至少一种允许相互作用的化合物所述化合物具有PTP1B和/或TC-PTP活性位点的特定残基。这些化合物可用于多种疾病的治疗或治疗，例如自身免疫性疾病，急性和慢性炎症，骨质疏松症，各种形式的癌症和恶性疾病，I型糖尿病和II型糖尿病以及分离中。 PTPase的鉴定以及其生物学功能的阐明或进一步阐明。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号